Toxicoproteomics: Applications in Drug Development

Authors: Gupta, N.; Law, A.; Poddar, R.; Louie, M.; Ray, A.; Chakravarti, D. N.

Source: Current Proteomics, Volume 2, Number 2, July 2005 , pp. 97-101(5)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $63.10 plus tax (Refund Policy)

Abstract:

Toxicoproteomics is the study of the effects of chemical exposure on tissues through identification and quantitative evaluation of changes occurring in the proteome profile. This approach has been and continues to be applied in the preclinical testing of drugs for precise as well as high-throughput determination of toxic effects. Several investigations have indicated that use of proteomics can lead to successful identification of potentially toxic compounds earlier in the drug development process. This review covers recent studies that have used simultaneous measurement of multiple protein markers for prediction of tissue toxicities. In addition, conventional and newer proteomic techniques have been evaluated for applicability to drug toxicology studies. The potential of toxicoproteomics to predict adverse drug reactions in clinical use have also been explored.

Keywords: proteomics; toxicoproteomics; drug toxicology; personalized medicine; hepatotoxicity; nephrotoxicity

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1570164054494181

Affiliations: 1: Keck Graduate Institute, 535 Watson Drive, Claremont, CA-91711, USA.

Publication date: 2005-07-01

More about this publication?

Current Proteomics research in the emerging field of proteomics is growing at an extremely rapid rate. The principal aim of Current Proteomics is to publish well-timed review articles in this fast-expanding area on topics relevant and significant to the development of proteomics. Current Proteomics is an essential journal for everyone involved in proteomics and related fields in both academia and industry.